Crossmark

RNA disruption is associated with response to multiple classes of chemotherapy drugs in tumor cell lines

Crossref DOI link: https://doi.org/10.1186/s12885-016-2197-1

Published Online: 2016-02-24

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Narendrula, Rashmi

Mispel-Beyer, Kyle

Guo, Baoqing

Parissenti, Amadeo M.

Pritzker, Laura B.

Pritzker, Ken

Masilamani, Twinkle

Wang, Xiaohui

Lannér, Carita http://orcid.org/0000-0002-7442-0142
Funding

Funding for this research was provided by:

Northern Cancer Research Foundation, Sudbury, Ontario, Canada (N/A)

Northern Ontario School of Medicine Faculty Association Research Development Fund, Ontario, Canada (N/A)

Ontario Institute for Cancer Research (02-MAY-0159)

Rna Diagnostics, Inc., Toronto, Ontario, Canada (Student stipend)

Rna Diagnostics, Inc., Toronto, Ontario, Canada (Student stipend)